2m 2m 2m 2m 2m 2m 2m
RHYTHM PHARM (RYTM)
NASDAQ
$89.20-$0.07 (-0.08%)
Price as of Oct 23, 2026 7:30 PM EDT- $6.1BMarket Cap
- -19.19%1-Year Change
- BiotechnologyIndustry
RHYTHM PHARM (RYTM)
$89.20-$0.07 (-0.08%)
RYTM | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $89.27 | ||
Change | -$1.63 (-1.79%) | ||
Open | $90.44 | ||
High | $90.44 | ||
Low | $88.56 | ||
Previous Close | $90.90 | ||
Volume | 536,980 | ||
30-Day Average Volume | 741,627 | ||
1-Week Change | 3.60% | ||
1-Month Change | -9.13% | ||
1-Year Change | -19.19% | ||
3-Year Change | 312.52% | ||
5-Year Change | 713.02% | ||
Fundamentals | |||
Shares Outstanding | 68.9M | ||
Total Assets | $437.3M | ||
Market Cap | $6.1B | ||
Enterprise Value | $6.2B | ||
Period: QTR TTM FY | |||
Revenue | $71.3M | ||
Net Income | -$49.3M | ||
Free Cash Flow | -$9.2M | ||
EBIT | -$48.9M | ||
EBITDA | -$48.7M | ||
Net Working Capital | $303.0M | ||
EPS | -$0.73 | ||
Enterprise Value/EBITDA | -127 | ||
Enterprise Value/Revenue | 87 | ||
P/B | 60 | ||
P/E | -122 | ||
PEG | -10 | ||
Price/Free Cash Flow | -672 | ||
Price/Operating Cash Flow | -672 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue